SCHEMBL24413636

SCHEMBL24413636

Cc1ccccc1Oc1ccc(OC(=O)C(F)(F)S(=O)(=O)O)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LPAR1 Q92633 3/20 0.43
LPAR5 Q9H1C0 3/20 0.43
FFAR1 O14842 2/20 0.41
ELANE P08246 2/20 0.41
AR P10275 1/20 0.40
MAPK14 Q16539 1/20 0.39
MMP1 P03956 1/20 0.39
MMP13 P45452 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
HTT P42858 2/20 0.39
TSHR P16473 1/20 0.39
GPR55 Q9Y2T6 1/20 0.39
ALDH1A1 P00352 3/20 0.39
LMNA P02545 1/20 0.39
CYP1A2 P05177 2/20 0.38
CYP2C9 P11712 2/20 0.38
CYP2C19 P33261 2/20 0.38
HPGD P15428 1/20 0.38
LTA4H P09960 1/20 0.38
EZH2 Q15910 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24414015 0.82 ELANE (0.37) FFAR1ELANEAR
SCHEMBL24413641 0.80 ELANE (0.47) FFAR1ELANEMMP1MMP13
SCHEMBL24413639 0.80 ELANE (0.37) LPAR1LPAR5FFAR1ELANEAR
SCHEMBL2605930 0.79 L3MBTL1 (0.43) ELANESMN1; SMN2ALDH1A1HPGDATM
SCHEMBL24414007 0.79 ELANE (0.36) ELANE
SCHEMBL2605893 0.77 PTPN1 (0.46) ELANESMN1; SMN2LMNACYP1A2CYP2C9
SCHEMBL13842668 0.76 ELANE (0.45) ELANEMMP1MMP13SMN1; SMN2LMNA
SCHEMBL27263062 0.76 ELANE (0.51) ELANEALDH1A1LMNAGAATDP1
SCHEMBL24413533 0.76 ELANE (0.46) ELANESMN1; SMN2ALDH1A1POLBL3MBTL1
SCHEMBL25844994 0.75 ELANE (0.47) ELANEALDH1A1POLBL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220146930-A1 SALT, ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2022-05-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220146930-A1 SALT, ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN RER1, FGFR1, NHERF1 LPAR1 126/4885LPAR5 897/4885FFAR1 33/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.